Suppr超能文献

单中心活体供肾移植术后糖尿病对移植肾失功的影响。

Effect of Posttransplant Diabetes Mellitus on Graft Loss After Living-Donor Kidney Transplant at a Single Institution.

作者信息

Maekawa Yuka Muramatsu, Horie Kengo, Iinuma Koji, Takai Manabu, Ohzawa Kaori, Tsuchiya Tomohiro, Kato Daiki, Taniguchi Tomoki, Ito Hiroki, Hishida Seiji, Nakane Keita, Mizutani Kosuke, Koie Takuya, Kato Taku

机构信息

Department of Urology, Gifu University Graduate School of Medicine, Gifu Japan.

Department of Urology, Japanese Red Cross Takayama Hospital, Takayama, Japan.

出版信息

Transplant Proc. 2020 Jan-Feb;52(1):162-168. doi: 10.1016/j.transproceed.2019.10.025. Epub 2019 Dec 31.

Abstract

BACKGROUND

This study aimed to evaluate predictive factors for graft loss in patients who received kidney transplantation (KT) from living kidney donors (LKDs) at a single institute in Japan.

METHODS

Our study focused on patients with end-stage renal disease who underwent KT from LKDs and were followed up for at least 1 year after surgery. The primary end point was graft survival (GS). GS after KT was analyzed using the Kaplan-Meier method. GS according to subgroup classification was analyzed using the log-rank test. A multivariate analysis was performed using a Cox proportional hazard model.

RESULTS

The median follow-up period was 105.5 months after KT. The 5- and 10-year GS rates were 97.8% and 96.0% in KT recipients (KTRs) without posttransplant diabetes mellitus (PTDM) and 89.9% and 63.2% in those with PTDM, respectively. The rate of graft loss was significantly higher in KTRs with PTDM than in those without PTDM (P < .001). Of the KTRs whose diabetes mellitus (DM) was cured after KT, those who underwent dialysis because of diabetic nephropathy had no graft loss. In the multivariate analysis, the serum creatinine level at 1 month after KT, PTDM, and human leukocyte antigen mismatches were significantly associated with graft loss after KT.

CONCLUSIONS

In this study, the rate of graft loss in KTRs with PTDM was significantly higher than that of KTRs without PTDM. However, among KTRs whose DM was cured after KT, those who underwent dialysis because of diabetic nephropathy had no graft loss.

摘要

背景

本研究旨在评估在日本一家机构接受活体肾移植(KT)的患者中移植肾丢失的预测因素。

方法

我们的研究聚焦于接受来自活体供肾者KT的终末期肾病患者,并在术后至少随访1年。主要终点是移植肾存活(GS)。采用Kaplan-Meier法分析KT后的GS。根据亚组分类的GS采用对数秩检验进行分析。使用Cox比例风险模型进行多变量分析。

结果

KT后的中位随访期为105.5个月。无移植后糖尿病(PTDM)的KT受者(KTRs)的5年和10年GS率分别为97.8%和96.0%,而有PTDM的患者分别为89.9%和63.2%。有PTDM的KTRs的移植肾丢失率显著高于无PTDM的患者(P <.001)。在KT后糖尿病(DM)治愈的KTRs中,因糖尿病肾病接受透析的患者无移植肾丢失。在多变量分析中,KT后1个月的血清肌酐水平、PTDM和人类白细胞抗原错配与KT后的移植肾丢失显著相关。

结论

在本研究中,有PTDM的KTRs的移植肾丢失率显著高于无PTDM的KTRs。然而,在KT后DM治愈的KTRs中,因糖尿病肾病接受透析的患者无移植肾丢失。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验